GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alivus Life Sciences Ltd (NSE:ALIVUS) » Definitions » PB Ratio

Alivus Life Sciences (NSE:ALIVUS) PB Ratio : 4.70 (As of Apr. 08, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Alivus Life Sciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-08), Alivus Life Sciences's share price is ₹973.15. Alivus Life Sciences's Book Value per Share for the quarter that ended in Dec. 2024 was ₹207.17. Hence, Alivus Life Sciences's PB Ratio of today is 4.70.

The historical rank and industry rank for Alivus Life Sciences's PB Ratio or its related term are showing as below:

NSE:ALIVUS' s PB Ratio Range Over the Past 10 Years
Min: 2.17   Med: 3.25   Max: 5.68
Current: 4.71

During the past 6 years, Alivus Life Sciences's highest PB Ratio was 5.68. The lowest was 2.17. And the median was 3.25.

NSE:ALIVUS's PB Ratio is ranked worse than
83.33% of 936 companies
in the Drug Manufacturers industry
Industry Median: 1.76 vs NSE:ALIVUS: 4.71

During the past 12 months, Alivus Life Sciences's average Book Value Per Share Growth Rate was 6.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 45.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 89.70% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Alivus Life Sciences was 185.70% per year. The lowest was 45.80% per year. And the median was 74.60% per year.

Back to Basics: PB Ratio


Alivus Life Sciences PB Ratio Historical Data

The historical data trend for Alivus Life Sciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alivus Life Sciences PB Ratio Chart

Alivus Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial - - 2.74 2.25 4.08

Alivus Life Sciences Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.08 - 5.10 -

Competitive Comparison of Alivus Life Sciences's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Alivus Life Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alivus Life Sciences's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alivus Life Sciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Alivus Life Sciences's PB Ratio falls into.


;
;

Alivus Life Sciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Alivus Life Sciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=973.15/207.174
=4.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Alivus Life Sciences  (NSE:ALIVUS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Alivus Life Sciences PB Ratio Related Terms

Thank you for viewing the detailed overview of Alivus Life Sciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alivus Life Sciences Business Description

Traded in Other Exchanges
Address
470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099
Alivus Life Sciences Ltd, formerly Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Alivus Life Sciences Headlines

No Headlines